Edgewise Therapeutics (EWTX) Current Leases (2022 - 2026)
Edgewise Therapeutics (EWTX) reported Current Leases of $1.0 million for Q1 2026, up 1.6% on a YoY basis from $1.0 million in Q1 2025, and little changed sequentially from $1.0 million in Q4 2025.
Edgewise Therapeutics (EWTX) Current Leases (2022 - 2026) Analysis & Trends
Edgewise Therapeutics (EWTX) has 5 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 1.6% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (up 1.6% YoY), and the FY2025 full-year result was $1.0 million, up 1.81% from the prior year.
- Current Leases was little changed at $1.0 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q1 2026 to a low of $104000.0 in Q2 2022.
- A 5-year average of $844062.5 and a median of $986000.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 738.46% in 2023 and increased 1.6% in 2026, its largest moves.
- Tracing EWTX's Current Leases over 5 years: stood at $608000.0 in 2022, then surged by 61.18% to $980000.0 in 2023, then advanced by 1.63% to $996000.0 in 2024, then gained by 1.81% to $1.0 million in 2025, then grew by 0.3% to $1.0 million in 2026.
- Business Quant data shows EWTX's Current Leases at $1.0 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 1.01 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 996,000.00 |
| Sep 30, 2024 | 992,000.00 |
| Jun 30, 2024 | 988,000.00 |
| Mar 31, 2024 | 984,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Sep 30, 2023 | 931,000.00 |
| Jun 30, 2023 | 872,000.00 |
| Mar 31, 2023 | 797,000.00 |
| Dec 31, 2022 | 608,000.00 |
| Sep 30, 2022 | 209,000.00 |
| Jun 30, 2022 | 104,000.00 |